Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shen Qu

Showing results (401-410 of 407) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 407 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2022
High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid NodulesHuixiong Xu, Yifeng Zhang, Hongxun Wu, et al.
BMJ (Clinical Research Ed.)|October 15, 2024
Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trialLiehua Liu, Weijian Ke, Hai Li, et al.
Nature Communications|October 7, 2020
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)Yifei Zhang, Yanyun Gu, Huahui Ren, et al.
Zhonghua Nei Ke Za Zhi|January 21, 2014
[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China]Chang-yu Pan, Wen-hui Li, Jiao-e Zeng, et al.
Environmental Science & Technology|June 25, 2021
U.S.-China Collaboration is Vital to Global Plans for a Healthy Environment and Sustainable DevelopmentMing Xu, Glen T Daigger, Chuanwu Xi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2015
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer VariantsXiaoguang Shi, Rengyun Liu, Fulvio Basolo, et al.
Nature Medicine|May 13, 2022
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialWenying Yang, Dalong Zhu, Shenglian Gan, et al.
Pageof 41

Showing results (401-410 of 407) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 407 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2022
High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid NodulesHuixiong Xu, Yifeng Zhang, Hongxun Wu, et al.
BMJ (Clinical Research Ed.)|October 15, 2024
Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trialLiehua Liu, Weijian Ke, Hai Li, et al.
Nature Communications|October 7, 2020
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)Yifei Zhang, Yanyun Gu, Huahui Ren, et al.
Zhonghua Nei Ke Za Zhi|January 21, 2014
[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China]Chang-yu Pan, Wen-hui Li, Jiao-e Zeng, et al.
Environmental Science & Technology|June 25, 2021
U.S.-China Collaboration is Vital to Global Plans for a Healthy Environment and Sustainable DevelopmentMing Xu, Glen T Daigger, Chuanwu Xi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2015
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer VariantsXiaoguang Shi, Rengyun Liu, Fulvio Basolo, et al.
Nature Medicine|May 13, 2022
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialWenying Yang, Dalong Zhu, Shenglian Gan, et al.
Pageof 41